ventureLAB and OBIO® have signed a Memorandum of Understanding (MOU) to partner on enabling Ontario-based healthtech and life sciences companies to scale, commercialize, and expand into global markets.
Through this partnership, ventureLAB and OBIO® will work together to strengthen the commercialization pathway for small and medium-sized enterprises (SMEs), helping them navigate complex regulatory environments, access new markets, and build globally competitive businesses. The collaboration bridges ventureLAB’s expertise in hardtech and deeptech commercialization with OBIO’s leadership in life sciences and health tech innovation and commercialization.
Read the full article: www.obio.ca
